Given the need for cellular morphology in clinical laboratories, hematology analyzer technology enjoys near universal application and its capabilities are expanding. In addition to cell counting and differential leukocyte analysis, reticulocyte count analysis can yield hemoglobin content, hypochromic cells, and microcytic cell or microcytic anemia factor. With these augmented capabilities, the utilization of this technology is projected to continue apace.
This marketplace will continue to be busy, as facilities of all sizes are planning new acquisitions.
Most new acquisitions (73%) are projected to occur over the next 4 years.
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.